Major ALS Research Funding Announced
MNI scientists will study stem cells, genetic mutations to develop new treatments
Researchers at the Montreal Neurological Institute of 平特五不中 who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada.
Olfactory perception influenced by background and semantic information
When two people smell the same thing, they can have remarkably different reactions, depending on their cultural background. Researchers at the Neuro have found that even when two cultures share the same language and many traditions, their reactions to the same smells can be different.
The Neuro Celebrates #GivingTuesday on November 29
#GivingTuesday is a global day of giving, created to counteract the consumerism-based Black Friday and Cyber Monday.
This year, The Neuro is celebrating #GivingTuesday by inviting the community to fund the Giving Tuesday Travel Award 鈥� which will allow a talented student or fellow to present their research at a national or international scientific meeting.
Evans receives Quebec honour
2016 Prix Wilder-Penfield recognizes monumental work in brain imaging and mapping
Dr. Alan Evans has become the latest researcher to receive the Province of Quebec鈥檚 most prestigious scientific award, the 2016 Prix Wilder-Penfield, named after The Neuro鈥檚 founder.听
Quebec federation honours Dr. Tampieri
Neuroradiologist recognized for her innovations in healthcare
Researchers identify gene associated with intracranial aneurysm in French-Canadian population
Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.
A Brilliant Success
A Brilliant Night raises $1 million for brain cancer research
A Brilliant Night raised an astounding $1 million for brain cancer research at its gala event on Oct. 19.
Essential tremor sufferers needed for groundbreaking study
You probably know someone who has it. It is the most common movement disorder, yet most people don鈥檛 even know its name.
Essential tremor affects nearly one per cent of the world鈥檚 population, increasing to four per cent of those over 40. The involuntary shaking of hands is the most common symptom, but symptoms can also include shaking of the head and legs.
The Neuro names Susan Cameron Cook Neuro-Palliative Care Program
The Montreal Neurological Institute and Hospital (The Neuro) is pleased to announce a new initiative designed to ease the suffering of seriously ill patients through specialized consultation and comprehensive care.
Dr. Guy Rouleau receives national award for significant contributions to world of science
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital at 平特五不中 and the 平特五不中 Health Centre, has been chosen to receive another major award recognizing his outstanding scientific career. The national organization representing Canadian francophone doctors, M茅decins francophones du Canada, is bestowing on him its 2016 Prix de l鈥檕euvre scientifique.
A Brilliant Night 2016
Inspiring event to raise money for brain cancer research
An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.
Team led by MNI researcher receive $6.1 million to study MS
A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.
The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.
Dr. Guy Rouleau elected to Royal Society of Canada
The Neuro鈥檚 director, Dr. Guy Rouleau, has received yet another honour in recognition of his sterling scientific career. The Royal Society of Canada (RSC) announced on Sept. 7 that its members had elected Dr. Rouleau as one of its new Fellows.
Continuing the fight against brain cancer
Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman
听
With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.
Researchers find new role for cannabinoids in vision
Chemicals shown to improve low-light vision of tadpoles by sensitizing retinal cells
A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
